Our guest this evening is Stanley D. Glick , Ph.D. , M.D., Professor Emeritus at Albany Medical College, who will be talking about his research on ibogaine and the ibogaine congener 18-MC (18-Methoxycoronaridine) and their potential as anti-addiction drugs.

Ibogaine, 18-MC, and Addiction

This series interviews experts in the addictions field, with a focus on evidence-based, cutting-edge approaches to substance abuse problems such as: Cognitive Behavioral Therapy (CBT), pharmacotherapy, harm reduction, and many, many more. Your host Kenneth Anderson is the founder and CEO of The HAMS Harm Reduction Network and the author of "How to Change Your Drinking: a Harm Reduction Guide to Alcohol."

Share Ibogaine, 18-MC, and Addiction

Sign up to save your podcasts

Ibogaine, 18-MC, and Addiction

Ibogaine, 18-MC, and Addiction